Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | OCLG |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Oncologix Tech Inc | 166.3K | 0.0x | --- |
Histogen Inc | 85.4K | 0.0x | --- |
Hypertension Diagnostics Inc | 280.0 | --- | --- |
Harrison Vickers and Waterman Inc | 10.1K | 0.0x | --- |
Sunvault Energy Inc | 302.9K | -0.1x | --- |
Drazcanna Inc | 164.2K | 0.0x | --- |
Oncologix Tech, Inc. is a shell company. The Company is a non-operating holding Company. The Company has no operations. The Company seeks to acquire an operating company via reverse merger.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $166.3K |
---|---|
Revenue (TTM) | $4.6M |
Shares Outstanding | 1.7B |
Oncologix Tech Inc does not pay a dividend. | |
Beta | 0.77 |
EPS | $-0.01 |
Book Value | $0.00 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12.87% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.